Acamprosate

This is a medicine sometimes used to help people who have stopped drinking alcohol stay sober. It works by helping to reduce cravings for alcohol.

Brand names:Campral
Medication

What people taking Acamprosate report

Every report comes from a Lived member, sent anonymously.

Have you tried Acamprosate for Alcoholism?

NameHow it went

About Acamprosate

What It's For

Acamprosate is a prescription medicine for alcohol use disorder (historically called alcohol dependence). Its job is specific: it helps people who have already stopped drinking stay alcohol-free. It was first sold under the brand name Campral, which is no longer marketed in the US; generic acamprosate tablets are what pharmacies supply today. Treatment begins once a person has stopped drinking and is through withdrawal. In the studies that led to its approval, it was not shown to help people who were still drinking when they started, and its benefit in people who also use other drugs has not been well studied. It is meant to be part of a wider plan that includes counseling, a support group or another form of ongoing support. Acamprosate is one of three medicines approved in the US for alcohol use disorder. The others are naltrexone, a pill or monthly injection that reduces the urge to drink, and disulfiram, which causes an unpleasant physical reaction if a person drinks. Acamprosate works differently from both.

How It Works

Long-term heavy drinking is thought to upset the brain's balance between two kinds of chemical signals: glutamate, which excites nerve cells, and GABA (gamma-aminobutyric acid), which calms them. When drinking stops, that imbalance may contribute to the uncomfortable feelings that can make a return to drinking more tempting. Acamprosate appears to act on these glutamate and GABA systems and is believed to help restore the balance, easing some of the discomfort people can feel during abstinence. Researchers do not fully understand how it works, and it does not block the effects of alcohol. Unlike disulfiram, it does not cause a reaction if someone drinks, and it is not a deterrent. It is a support that makes staying abstinent somewhat easier.

Dosage & Administration

Acamprosate comes as a delayed-release tablet. The coating keeps it from dissolving until it reaches the intestine, so the tablets are swallowed whole, not split, crushed or chewed. The usual dose is two 333 mg tablets taken three times a day. It can be taken with or without food, though taking it with meals, as was done in the original trials, is a practical way to remember three doses for people who eat three meals a day. People with moderately reduced kidney function are usually started on one tablet three times a day. If a dose is missed, take it when you remember unless the next dose is nearly due; do not double up. The three-times-daily schedule is one of the medicine's main practical demands, and it is worth planning how doses will fit into work and home routines before starting.

Side Effects

Diarrhea is the most common side effect. In the original trials it affected about 1 in 6 people at the usual dose, compared with about 1 in 10 taking a placebo (a dummy pill), and it is the side effect that most often leads people to stop. Gas, nausea, itching, sweating, trouble sleeping, anxiety, weakness, dizziness and dry mouth can also occur. Most of these are mild, and in the trials only slightly more people stopped acamprosate because of side effects than stopped the placebo. Burning, tingling or numbness in the hands, feet, arms or legs, or a new rash, is uncommon and should be reported to the prescriber right away. Depression and suicidal thoughts are common in alcohol use disorder, and in trials suicidal thoughts and actions, though infrequent, were reported more often with acamprosate than with placebo. New or worsening low mood, hopelessness, loss of interest in things, or thoughts of harming yourself call for contacting the prescriber right away, whether or not you have been drinking. It helps if family members know these signs too.

Interactions & Warnings

Acamprosate has few drug interactions. It is not broken down by the liver, and studies found no meaningful interactions with naltrexone, disulfiram or diazepam (a benzodiazepine sedative). The prescriber and pharmacist should still know about every medicine and supplement you take. It can affect thinking and coordination in some people, so it makes sense to see how it affects you before driving or operating machinery. The kidneys clear acamprosate from the body, so kidney function matters more than with many medicines. Kidney function is often described by creatinine clearance, an estimate from blood tests of how well the kidneys filter waste; lower numbers mean weaker filtering. At a creatinine clearance of 30 to 50 mL/min (moderate impairment) the dose is reduced, and at 30 or below (severe impairment) acamprosate is not used. Older adults are more likely to have reduced kidney function, so a kidney check before and during treatment may be sensible. Rare cases of sudden kidney failure have been reported. Mild to moderate liver disease, which is common after years of heavy drinking, does not require a dose change. People who have had an allergic reaction to acamprosate should not take it. Acamprosate does not prevent or ease alcohol withdrawal symptoms. Withdrawal needs its own plan before acamprosate starts. Animal studies found birth defects at doses close to those used in people, and there are no adequate studies in pregnancy, although alcohol itself is known to harm a developing baby. Anyone who is pregnant, planning a pregnancy or breastfeeding should discuss the balance of risks with the prescriber.

What to Expect

Acamprosate does not remove the desire to drink overnight or make drinking impossible. What it offers is a better chance of staying abstinent. In pooled trials of people who had recently stopped drinking, roughly one more person out of every 9 to 12 treated avoided returning to any drinking compared with placebo, and people on acamprosate stayed abstinent for longer overall. It has not been shown to reduce heavy drinking once drinking resumes, so it fits best when the goal is not drinking at all. In head-to-head trials, acamprosate and naltrexone worked about equally well, so the choice between them often comes down to dosing schedule, side effects, kidney and liver health and personal goals. The medicine helps only while it is being taken, so it is usually continued even when someone feels confident about staying sober. If drinking happens, keep taking acamprosate and tell the prescriber; a slip is a reason to review the plan, not to stop the medicine. The original trials lasted from three months to a year, and how long to continue is a decision to make with the care team. Counseling and support remain the foundation; acamprosate adds to them rather than replacing them.

Questions to Ask Your Doctor

  1. 1.Why is acamprosate a better fit for me than naltrexone or disulfiram?
  2. 2.Is my kidney function good enough for the standard dose, and will it be checked during treatment?
  3. 3.How can I manage diarrhea or stomach upset if it happens?
  4. 4.What counseling or support should I pair with this medicine, and how will we judge whether it is helping?
  5. 5.How long should I plan to take it, and what should I do if I drink again?

Last reviewed • Oct 2026

Educational content, not medical advice.